Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Stem Cell Transplantation in Parkinson's Disease
NCT03309514Phase 2Withdrawn
- Sponsor
- NeuroGeneration
- Start
- Jun 2022
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of NGN-9076 in Parkinson's disease (PD), sponsored by NeuroGeneration. Planned start Jun 2022; status: withdrawn.
02
Drugs
NGN-9076
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03309514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03309514.